This suggests that the role of Notch/NF-κB pathway is not specific to drug selection, and downregulating TBK1 expression is also a broad-spectrum, molecular-targeted-drug sensitization strategy in HCC. Here, NFKB1 is linked to hepatocellular carcinoma.